C4 Therapeutics, Inc.
- Last sale
- Nov 6, 2026 · +4.22%
- Market cap
- $405.11M
- 131.32M shares
- Filings
- 552
Q3 2026+1.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+34.4% FY25 yoy
- $405.11M
- —
- 12.6×
- 1.8×
- -19.68%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $35,947,000 | reported | |
| FY 2024 | 2024-12-31 | $35,584,000 | reported | |
| FY 2023 | 2023-12-31 | $20,756,000 | reported | |
| FY 2022 | 2022-12-31 | $31,096,000 | reported | |
| FY 2021 | 2021-12-31 | $45,785,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $193.00K | $193.00K | — | 97.58M sh | +37.5% | — |
| FY2024 | — | $194.00K | $194.00K | — | 70.99M sh | +3.5% | — |
| FY2023 | — | $110.00K | $110.00K | — | 68.60M sh | +13.5% | — |
| FY2022 | — | $0.00 | $0.00 | — | 60.47M sh | +24.1% | — |
| FY2020 | — | $194.00K | $194.00K | — | 43.12M sh | +2,922.4% | — |
Biological products, except diagnostic substances
C4 Therapeutics, Inc. is the 50th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
FENCFennec Pharmaceuticals Inc.$44.6M6.1%21.8%$381.4MCHRSCoherus Oncology, Inc.$42.2M59.8%398.4%$83.4MEDITEditas Medicine, Inc.$40.5M25.4%395.0%$329.5MVYGRVoyager Therapeutics, Inc.$40.4M49.5%296.5%$105.8MSGMOQSangamo Therapeutics, Inc$39.6M31.6%310.8%$49.7MKYMRKymera Therapeutics, Inc.$39.2M16.7%794.0%$10.9B
CCCCC4 Therapeutics, Inc. (this company)$35.9M1.0%292.1%$405.1M
XFORX4 Pharmaceuticals, Inc$35.1M1,273.2%225.6%$324.2MSCLXScilex Holding Co$30.3M46.5%1,236.4%$13.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
C4 Therapeutics, Inc. · CIK 1662579 · Engraved from SEC EDGAR